サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1756464

治療用低体温療法システムの世界市場：製品種類別・用途別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)

Therapeutic Hypothermia Systems Market, By Product Type, By Application, By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 399 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
治療用低体温療法システムの世界市場：製品種類別・用途別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)
出版日: 2025年05月15日
発行: AnalystView Market Insights
ページ情報: 英文 399 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

治療用低体温療法システムの市場規模は2024年に3億380万米ドルとなり、2024年から2032年にかけてCAGR 6.50%で拡大

治療用低体温療法システムの市場力学

心停止と神経疾患の発生率の増加

心停止と神経疾患の有病率の増加は、治療用低体温療法システムの需要を促進する主要な促進要因です。世界的に、院外心停止（OHCA）は毎年数十万人に影響を及ぼしており、効果的な蘇生後のケアがなければ生存率は低いままです。治療用低体温療法は、このような症例において神経学的回復を改善し、死亡率を低下させるための標準的な介入として登場しました。さらに、外傷性脳損傷（TBI）、脳卒中、新生児脳症の症例が増加し、管理された冷却が臨床的に有益であることが示されたため、これらのシステムの導入がさらに加速しています。緊急対応インフラストラクチャーの進歩に加え、標的体温管理のための治療用低体温療法を推奨する臨床ガイドラインの更新が、クリティカルケアプロトコルへの統合を後押ししています。さらに、心血管系や神経系に影響を受けやすい世界人口の高齢化は、長期的な需要を維持すると思われます。これらの要因が総合的に、医療環境における効率的で使い勝手のよい治療用低体温療法技術に対するニーズの高まりを強調しています。

治療用低体温療法システム市場：主な考察

当社のリサーチアナリストによると、世界の治療用低体温療法システム市場は、2024年から2032年の間に約6.50％のCAGRで発展すると予測されています。

製品種類別では、2023年に冷却装置が市場を独占しています。

用途別では、2023年に心臓病が最も収益を上げました。

地域別では、2023年に北米が最も収益を上げた地域でした。

治療用低体温療法システム市場：セグメンテーション分析

世界の治療用低体温療法システム市場は、製品タイプ、用途、最終用途、地域の3つに分類されます。

治療用低体温療法システム市場は、製品種類別に冷却装置、冷却カテーテル、冷却パック、その他の製品種類に区分されます。このうち、冷却装置は、高度な温度制御、使いやすさ、さまざまな医療緊急事態における広範な臨床適用性により、市場を独占すると予測されています。これらのデバイスには、冷却毛布、パッド、自動体温調節ユニットなどの表面冷却システムが含まれ、正確かつ迅速な体温管理を提供します。非侵襲的な性質と、一貫して制御された低体温療法を提供する能力を併せ持つことから、集中治療室、救急部、外科の現場で非常に好まれています。持ち運び可能な自動化システムなど、冷却装置の設計における技術的進歩は、その採用をさらに促進しています。さらに、心停止や神経損傷における早期体温介入の利点に対する認識が高まるにつれ、医療提供者は高性能冷却装置への投資を増やしています。また、成人患者と小児患者の両方に対応できることから、応用範囲も広がっています。さらに、米国心臓協会（AHA）のような機関からの有利な償還政策や支持的な臨床ガイドラインにより、主要製品タイプとしての地位が強化されています。これらの利点は総体的に、治療用低体温療法システム市場における冷却装置の継続的な優位性に寄与しています。

治療用低体温療法システム市場は用途別に、神経症、心臓病、新生児医療、その他の用途に区分されます。なかでも循環器科は、心停止の発生率の上昇と蘇生後の標的体温管理（TTM）の採用拡大が主な要因となって、市場を独占すると予想されています。治療用低体温療法は、突然の心停止に陥った患者の生存率と神経学的転帰を改善することが臨床的に検証されています。世界の心血管系疾患の罹患率は上昇を続けており、特に高齢化社会の中で、循環器内科における低体温療法システムの需要は着実に増加すると予想されます。さらに、主要な医療機関の確立された臨床ガイドラインでは、心停止後の制御低体温療法の使用が強く推奨されており、心臓治療の現場における低体温療法の普及をさらに後押ししています。臨床的有効性、認知度の向上、技術の進歩の組み合わせにより、心臓病がこの市場の主要な応用分野であり続けることが確実です。

治療用低体温療法システム市場：地域別分析

地域的には、治療用低体温療法システム市場は北米、アジア太平洋、ラテンアメリカ、欧州、中東・アフリカに分布しています。これらの地域は、ビジネスをもたらしている国に基づいてさらに分割されます。

北米が市場をリードすると予測される主な理由は、高度な医療インフラの存在、心停止後のケアに対する高い認識、米国やカナダなどの国々における有利な償還政策などです。特に米国では、強力な臨床ガイドラインと政府の資金援助に支えられ、病院や救急治療室で治療用低体温療法システムが広く採用されています。

欧州は、確立された医療プロトコール、高齢化人口の増加、集中治療技術への強力な投資によって、2番目の主要地域となっています。ドイツ、英国、フランスなどの国々が主要な導入国であり、公的および民間医療支援による恩恵を受けています。北米と欧州は、早期の技術導入と強固な臨床的枠組みによりシェアの大半を占めています。

治療用低体温療法システム市場：競合情勢

治療用低体温療法システム市場の競合情勢は、世界の医療機器大手と新興イノベーターによって形成されています。旭化成株式会社（ZOLL Medical Corporation）、ベクトン・ディッキンソン・アンド・カンパニー（Becton, Dickinson and Company）、ストライカー・コーポレーション（Stryker Corporation）などの主要企業は、包括的なポートフォリオと世界な展開により、この市場を独占しています。これらの企業は、精密冷却技術の進歩、安全性の向上、規制遵守の徹底のため、研究開発に多額の投資を行っています。一方、Belmont Medical Technologies、Life Recovery Systems、PFM Medical HICO GmbHなどの中堅企業は、ポータブル冷却ソリューションや新生児冷却ソリューションなど、特定の用途に注力しています。MiraCradle（Pluss Advanced Technologies Pvt.Ltd.）やVNG Medical Innovation System Pvt.Ltd.などの新興企業は、発展途上地域をターゲットとした費用対効果の高い革新的な機器を重視しています。2023年6月のベクトン・ディッキンソンの戦略的売却のような最近の動きは、進行中のポートフォリオ再編成を示唆しています。競合は技術革新を促進し、クリティカルケアの現場での採用を後押しし、継続的な製品強化と地域拡大を通じて患者の転帰を改善します。

目次

第1章 治療用低体温療法システム市場の概要

  • 分析範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 治療用低体温療法システムの主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 治療用低体温療法システム市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 治療用低体温療法システム市場：新型コロナウイルス感染症 (COVID-19) の影響分析

  • COVID-19以前の影響分析
  • COVID-19以降の影響分析

第6章 治療用低体温療法システムの市場情勢

  • 治療用低体温療法システムの市場シェア分析 (2023年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 治療用低体温療法システム市場：製品種類別

  • 概要
    • セグメント別シェア分析：製品種類別
    • 冷却装置
    • 冷却カテーテル
    • 冷却パック
    • その他の製品種類

第8章 治療用低体温療法システム市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • 神経症
    • 心臓病
    • 新生児医療
    • その他の用途

第9章 治療用低体温療法システム市場：最終用途別

  • 概要
    • セグメント別シェア分析：最終用途別
    • 病院
    • 専門クリニック
    • 外来手術センター

第10章 治療用低体温療法システム市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 韓国
    • 日本
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：治療用低体温療法システム業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Asahi Kasei Corporation（Zoll Medical Corporation）
    • Becton, Dickinson And Company
    • Stryker Corporation
    • Belmont Medical Technologies
    • International Biomedical Ltd.
    • Em-Med
    • Phoenix Medical Systems
    • Life Recovery Systems
    • Shenzhen Comen Medical Instruments Co., Ltd.
    • Miracradle（Pluss Advanced Technologies Pvt. Ltd.）
    • Terumo Cardiovascular Systems Corporation
    • Pfm Medical Hico Gmbh
    • Vng Medical Innovation System Pvt. Ltd
    • Aspen Systems
    • Cooltech Medical
    • Others

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV5327

REPORT HIGHLIGHT

Therapeutic Hypothermia Systems Market size was valued at USD 303.8 Million in 2024, expanding at a CAGR of 6.50% from 2024 to 2032.

Therapeutic hypothermia systems are medical devices designed to lower a patient's body temperature in a controlled manner to reduce the risk of tissue damage following events such as cardiac arrest, traumatic brain injury, or stroke. These systems work by cooling the body to a target temperature usually between 32°C and 36°C to slow metabolic processes, decrease oxygen demand, and limit the cascade of cellular damage. The cooling can be achieved through surface methods, such as cooling blankets or pads, or internal methods using catheters that circulate cooled fluids. Advanced systems allow for precise temperature control, rewarming, and continuous monitoring. Therapeutic hypothermia has been shown to improve neurological outcomes and survival rates when applied shortly after a critical medical event. These systems are used primarily in intensive care units, emergency settings, and surgical procedures. The effectiveness of therapeutic hypothermia depends on timely initiation, duration of cooling, and patient-specific considerations.

Therapeutic Hypothermia Systems Market- Market Dynamics

Rising Incidence of Cardiac Arrest and Neurological Disorders

The growing prevalence of cardiac arrest and neurological conditions is a key driver propelling the demand for therapeutic hypothermia systems. Globally, out-of-hospital cardiac arrests (OHCA) affect hundreds of thousands of individuals annually, with survival rates remaining low without effective post-resuscitation care. Therapeutic hypothermia has emerged as a standard intervention to improve neurological recovery and reduce mortality in such cases. Additionally, increasing cases of traumatic brain injury (TBI), stroke, and neonatal encephalopathy conditions where controlled cooling has shown clinical benefits are further accelerating the adoption of these systems. Advancements in emergency response infrastructure, along with updated clinical guidelines recommending therapeutic hypothermia for targeted temperature management, are supporting its integration into critical care protocols. Moreover, the aging global population, which is more susceptible to cardiovascular and neurological events, is likely to sustain long-term demand. These factors collectively underscore the growing need for efficient, user-friendly therapeutic hypothermia technologies in healthcare settings.

THERAPEUTIC HYPOTHERMIA SYSTEMS Market- Key Insights

According to our research analyst, the global Therapeutic Hypothermia Systems Market is expected to develop at a CAGR of approximately 6.50% between 2024-2032.

Segmented by Product Type in 2023, the Cooling Devices category dominated the market.

Based on Application segmentation, Cardiology generated the most income in 2023.

Based on region, in 2023, North America was the region with the highest revenue.

Therapeutic Hypothermia Systems Market- Segmentation Analysis:

The global Therapeutic Hypothermia Systems market is divided into three categories: product type, application, end use and region.

The therapeutic hypothermia systems market is segmented by product type into Cooling Devices, Cooling Catheters, Cooling Packs, and Other Product Types. Among these, Cooling Devices are projected to dominate the market due to their advanced temperature control, ease of use, and broad clinical applicability across various medical emergencies. These devices include surface cooling systems such as cooling blankets, pads, and automated temperature regulation units that offer precise and rapid body temperature management. Their non-invasive nature, combined with the ability to provide consistent and controlled hypothermia therapy, makes them highly preferred in intensive care units, emergency departments, and surgical settings. Technological advancements in cooling device design, including portable and automated systems, have further enhanced their adoption. Moreover, as awareness grows around the benefits of early temperature intervention in cardiac arrest and neurological injuries, healthcare providers are increasingly investing in high-performance cooling devices. Their capability to cater to both adult and pediatric patients also broadens their application scope. Additionally, favorable reimbursement policies and supportive clinical guidelines from institutions like the American Heart Association (AHA) reinforce their position as the leading product type. These advantages collectively contribute to the expected continued dominance of cooling devices in the therapeutic hypothermia systems market.

The therapeutic hypothermia systems market is segmented by application into Neurology, Cardiology, Neonatal Care, and Other Applications. Among these, Cardiology is expected to dominate the market, driven primarily by the rising incidence of cardiac arrest and the growing adoption of targeted temperature management (TTM) post-resuscitation. Therapeutic hypothermia has been clinically validated to improve survival rates and neurological outcomes in patients who suffer from sudden cardiac arrest, especially when implemented within a critical time window. As global cardiovascular disease rates continue to climb, particularly among aging populations, the demand for hypothermia systems in cardiology is anticipated to increase steadily. Furthermore, established clinical guidelines from major health organizations strongly recommend the use of controlled hypothermia following cardiac arrest, further reinforcing its widespread application in cardiac care settings. The combination of clinical efficacy, growing awareness, and technological advancements ensures cardiology remains the leading application segment within this market.

Therapeutic Hypothermia Systems Market- Geographical Insights

Geographically, the Therapeutic Hypothermia Systems Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is projected to lead the market, primarily due to the presence of advanced healthcare infrastructure, high awareness of post-cardiac arrest care, and favorable reimbursement policies in countries such as the United States and Canada. The U.S., in particular, has widespread adoption of therapeutic hypothermia systems across hospitals and emergency care units, supported by strong clinical guidelines and government funding.

Europe follows as the second dominant region, driven by established medical protocols, a rising aging population, and strong investments in intensive care technologies. Countries such as Germany, the United Kingdom, and France are leading adopters, benefitting from both public and private healthcare support. Together, North America and Europe account for the majority share due to early technology adoption and robust clinical frameworks.

Therapeutic Hypothermia Systems Market- Competitive Landscape:

The competitive landscape of the Therapeutic Hypothermia Systems market is shaped by a mix of global medical device giants and emerging innovators. Leading players such as ASAHI KASEI CORPORATION (ZOLL Medical Corporation), Becton, Dickinson and Company, and Stryker Corporation dominate the space through comprehensive portfolios and global reach. These companies invest substantially in R&D to advance precision cooling technologies, enhance safety, and ensure regulatory compliance. Meanwhile, mid-sized firms like Belmont Medical Technologies, Life Recovery Systems, and PFM Medical HICO GmbH focus on specific applications, including portable and neonatal cooling solutions. Emerging players such as MiraCradle (Pluss Advanced Technologies Pvt. Ltd.) and VNG Medical Innovation System Pvt. Ltd. emphasize cost-effective and innovative devices targeting developing regions. Recent moves, like Becton Dickinson's strategic divestments in June 2023, signal ongoing portfolio realignment. The competition fosters innovation, boosts adoption across critical care settings, and improves patient outcomes through continuous product enhancement and geographic expansion.

Recent Developments:

In January 2024, SourceMark Medical expanded its partnership with Gentherm Medical, becoming the master supplier of Gentherm's patient temperature management products, including the Gelli-Roll reusable warming and cooling gel pad, in the U.S. market.

In July 2023, ZOLL Medical entered into an exclusive distribution agreement with BrainCool AB for the BrainCool System/IQool System and IQool System Pads in the U.S. and key European markets, with plans to expand into select Asian markets.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Asahi Kasei Corporation (Zoll Medical Corporation)
  • Becton, Dickinson And Company
  • Stryker Corporation
  • Belmont Medical Technologies
  • International Biomedical Ltd.
  • Em-Med
  • Phoenix Medical Systems
  • Life Recovery Systems
  • Shenzhen Comen Medical Instruments Co., Ltd.
  • Miracradle (Pluss Advanced Technologies Pvt. Ltd.)
  • Terumo Cardiovascular Systems Corporation
  • Pfm Medical Hico Gmbh
  • Vng Medical Innovation System Pvt. Ltd
  • Aspen Systems
  • Cooltech Medical
  • Others

GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Cooling Devices
  • Cooling Catheters
  • Cooling Packs
  • Other Product Types

GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Neurology
  • Cardiology
  • Neonatal Care
  • Other Applications

GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Therapeutic Hypothermia Systems Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Therapeutic Hypothermia Systems Market Snippet by Product Type
    • 2.1.2. Therapeutic Hypothermia Systems Market Snippet by Application
    • 2.1.3. Therapeutic Hypothermia Systems Market Snippet by End Use
    • 2.1.4. Therapeutic Hypothermia Systems Market Snippet by Country
    • 2.1.5. Therapeutic Hypothermia Systems Market Snippet by Region
  • 2.2. Competitive Insights

3. Therapeutic Hypothermia Systems Key Market Trends

  • 3.1. Therapeutic Hypothermia Systems Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Therapeutic Hypothermia Systems Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Therapeutic Hypothermia Systems Market Opportunities
  • 3.4. Therapeutic Hypothermia Systems Market Future Trends

4. Therapeutic Hypothermia Systems Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Therapeutic Hypothermia Systems Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Therapeutic Hypothermia Systems Market Landscape

  • 6.1. Therapeutic Hypothermia Systems Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Therapeutic Hypothermia Systems Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Cooling Devices
    • 7.1.3. Cooling Catheters
    • 7.1.4. Cooling Packs
    • 7.1.5. Other Product Types

8. Therapeutic Hypothermia Systems Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Neurology
    • 8.1.3. Cardiology
    • 8.1.4. Neonatal Care
    • 8.1.5. Other Applications

9. Therapeutic Hypothermia Systems Market - By End Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Specialty Clinics
    • 9.1.4. Ambulatory Surgival Centers

10. Therapeutic Hypothermia Systems Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Therapeutic Hypothermia Systems Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Therapeutic Hypothermia Systems Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Therapeutic Hypothermia Systems Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Therapeutic Hypothermia Systems Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Therapeutic Hypothermia Systems Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Therapeutic Hypothermia Systems Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Asahi Kasei Corporation (Zoll Medical Corporation)
    • 11.2.2. Becton, Dickinson And Company
    • 11.2.3. Stryker Corporation
    • 11.2.4. Belmont Medical Technologies
    • 11.2.5. International Biomedical Ltd.
    • 11.2.6. Em-Med
    • 11.2.7. Phoenix Medical Systems
    • 11.2.8. Life Recovery Systems
    • 11.2.9. Shenzhen Comen Medical Instruments Co., Ltd.
    • 11.2.10. Miracradle (Pluss Advanced Technologies Pvt. Ltd.)
    • 11.2.11. Terumo Cardiovascular Systems Corporation
    • 11.2.12. Pfm Medical Hico Gmbh
    • 11.2.13. Vng Medical Innovation System Pvt. Ltd
    • 11.2.14. Aspen Systems
    • 11.2.15. Cooltech Medical
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us